- Home
- MEDP vs HIMS Comparison
MEDP vs HIMS Comparison
Compare MEDP & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- HIMS
- Stock Information
- Founded
- MEDP 1992
- HIMS 2017
- Country
- MEDP United States
- HIMS United States
- Employees
- MEDP N/A
- HIMS N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- HIMS Medical/Nursing Services
- Sector
- MEDP Health Care
- HIMS Health Care
- Exchange
- MEDP Nasdaq
- HIMS Nasdaq
- Market Cap
- MEDP 8.5B
- HIMS 9.4B
- IPO Year
- MEDP 2016
- HIMS N/A
- Fundamental
- Price
- MEDP $311.87
- HIMS $50.37
- Analyst Decision
- MEDP Hold
- HIMS Hold
- Analyst Count
- MEDP 11
- HIMS 11
- Target Price
- MEDP $338.90
- HIMS $40.73
- AVG Volume (30 Days)
- MEDP 387.7K
- HIMS 43.2M
- Earning Date
- MEDP 07-21-2025
- HIMS 08-04-2025
- Dividend Yield
- MEDP N/A
- HIMS N/A
- EPS Growth
- MEDP 33.36
- HIMS N/A
- EPS
- MEDP 13.09
- HIMS 0.68
- Revenue
- MEDP $2,156,580,000.00
- HIMS $1,784,353,000.00
- Revenue This Year
- MEDP $5.69
- HIMS $62.27
- Revenue Next Year
- MEDP $3.36
- HIMS $19.82
- P/E Ratio
- MEDP $23.83
- HIMS $73.88
- Revenue Growth
- MEDP 9.87
- HIMS 85.99
- 52 Week Low
- MEDP $250.05
- HIMS $13.47
- 52 Week High
- MEDP $441.27
- HIMS $72.98
- Technical
- Relative Strength Index (RSI)
- MEDP 48.47
- HIMS 49.61
- Support Level
- MEDP $309.97
- HIMS $49.40
- Resistance Level
- MEDP $334.33
- HIMS $53.24
- Average True Range (ATR)
- MEDP 8.95
- HIMS 2.90
- MACD
- MEDP -1.21
- HIMS 0.24
- Stochastic Oscillator
- MEDP 13.38
- HIMS 65.03
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the US, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About HIMS Hims & Hers Health Inc.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.